Table 1. Approximate treatment success per protocol with susceptible strains (Western results)1.
| Therapy | Days | Success |
|---|---|---|
| Clarithromycin triple therapy | 7 | 94% |
| Clarithromycin triple therapy | 14 | 97% |
| Sequential therapy | 10 | 94% |
| Sequential therapy | 14 | 97% |
| Hybrid therapy | 14 | 97% |
| Fluoroquinolone triple | 7 | <80% |
| Fluoroquinolone triple | 10 | <90% |
| Fluoroquinolone triple | 14 | 96% |
| PPI + amoxicillin1 | 5 | 10% |
| PPI + amoxicillin1 | 7 | 15% |
| PPI + amoxicillin | 10 | 20% |
| PPI + amoxicillin1 | 14 | 50% |
| PPI metronidazole triple | 7 | 94% |
| PPI metronidazole triple | 14 | 97% |
| PPI- bismuth tetracycline, metronidazole | 14 | >95% |
1
=Equals triple therapies but with clari, met, or fluoroquinolone resistance infections